Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259T Cells in Synovial Sarcoma.

D'Angelo SP, Melchiori L, Merchant MS, Bernstein D, Glod J, Kaplan R, Grupp S, Tap WD, Chagin K, Binder GK, Basu S, Lowther DE, Wang R, Bath N, Tipping A, Betts G, Ramachandran I, Navenot JM, Zhang H, Wells DK, Van Winkle E, Kari G, Trivedi T, Holdich T, Pandite L, Amado R, Mackall CL.

Cancer Discov. 2018 Aug;8(8):944-957. doi: 10.1158/2159-8290.CD-17-1417. Epub 2018 Jun 11.

PMID:
29891538
2.

Effects of developmental lead exposure on the hippocampal methylome: Influences of sex and timing and level of exposure.

Singh G, Singh V, Wang ZX, Voisin G, Lefebvre F, Navenot JM, Evans B, Verma M, Anderson DW, Schneider JS.

Toxicol Lett. 2018 Jun 15;290:63-72. doi: 10.1016/j.toxlet.2018.03.021. Epub 2018 Mar 20.

3.

A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma.

O'Rourke DM, Nasrallah MP, Desai A, Melenhorst JJ, Mansfield K, Morrissette JJD, Martinez-Lage M, Brem S, Maloney E, Shen A, Isaacs R, Mohan S, Plesa G, Lacey SF, Navenot JM, Zheng Z, Levine BL, Okada H, June CH, Brogdon JL, Maus MV.

Sci Transl Med. 2017 Jul 19;9(399). pii: eaaa0984. doi: 10.1126/scitranslmed.aaa0984.

4.

Heme oxygenase-1 gene promoter polymorphism is associated with the development of necrotizing acute pancreatitis.

Gulla A, Evans BJ, Navenot JM, Pundzius J, Barauskas G, Gulbinas A, Dambrauskas Z, Arafat H, Wang ZX.

Pancreas. 2014 Nov;43(8):1271-6. doi: 10.1097/MPA.0000000000000171.

PMID:
25036905
5.

Characterization of the receptor binding residues of kisspeptins by positional scanning using peptide photoaffinity probes.

Misu R, Oishi S, Setsuda S, Noguchi T, Kaneda M, Ohno H, Evans B, Navenot JM, Peiper SC, Fujii N.

Bioorg Med Chem Lett. 2013 May 1;23(9):2628-31. doi: 10.1016/j.bmcl.2013.02.098. Epub 2013 Mar 4.

PMID:
23522565
6.

MicroRNA profiling in lung cancer reveals new molecular markers for diagnosis.

Solomides CC, Evans BJ, Navenot JM, Vadigepalli R, Peiper SC, Wang ZX.

Acta Cytol. 2012;56(6):645-54. doi: 10.1159/000343473. Epub 2012 Nov 24.

PMID:
23207443
7.

Paradoxical downregulation of CXC chemokine receptor 4 induced by polyphemusin II-derived antagonists.

Masuda R, Oishi S, Tanahara N, Ohno H, Hirasawa A, Tsujimoto G, Yano Y, Matsuzaki K, Navenot JM, Peiper SC, Fujii N.

Bioconjug Chem. 2012 Jun 20;23(6):1259-65. doi: 10.1021/bc300084h. Epub 2012 May 9.

PMID:
22486464
8.

The metastasis suppressor KISS1 lacks antimetastatic activity in the C8161.9 xenograft model of melanoma.

Navenot JM, Evans B, Oishi S, Setsuda S, Fujii N, Peiper SC.

Melanoma Res. 2012 Apr;22(2):140-50. doi: 10.1097/CMR.0b013e328350fa07.

PMID:
22395416
9.

Pan-histone deacetylase inhibitor panobinostat depletes CXCR4 levels and signaling and exerts synergistic antimyeloid activity in combination with CXCR4 antagonists.

Mandawat A, Fiskus W, Buckley KM, Robbins K, Rao R, Balusu R, Navenot JM, Wang ZX, Ustun C, Chong DG, Atadja P, Fujii N, Peiper SC, Bhalla K.

Blood. 2010 Dec 9;116(24):5306-15. doi: 10.1182/blood-2010-05-284414. Epub 2010 Sep 1.

10.

Activation of Rho and Rho-associated kinase by GPR54 and KiSS1 metastasis suppressor gene product induces changes of cell morphology and contributes to apoptosis.

Navenot JM, Fujii N, Peiper SC.

Mol Pharmacol. 2009 Jun;75(6):1300-6. doi: 10.1124/mol.109.055095. Epub 2009 Mar 13.

PMID:
19286835
11.

KiSS1 metastasis suppressor gene product induces suppression of tyrosine kinase receptor signaling to Akt, tumor necrosis factor family ligand expression, and apoptosis.

Navenot JM, Fujii N, Peiper SC.

Mol Pharmacol. 2009 May;75(5):1074-83. doi: 10.1124/mol.108.054270. Epub 2009 Feb 6.

PMID:
19201817
12.

Physical association of GPR54 C-terminal with protein phosphatase 2A.

Evans BJ, Wang Z, Mobley L, Khosravi D, Fujii N, Navenot JM, Peiper SC.

Biochem Biophys Res Commun. 2008 Dec 26;377(4):1067-71. doi: 10.1016/j.bbrc.2008.10.108. Epub 2008 Oct 31.

PMID:
18977201
13.

Heat shock response in CHO mammalian cells is controlled by a nonlinear stochastic process.

Lipan O, Navenot JM, Wang Z, Huang L, Peiper SC.

PLoS Comput Biol. 2007 Oct;3(10):1859-70. Epub 2007 Aug 13.

14.

Association of nucleophosmin negatively regulates CXCR4-mediated G protein activation and chemotaxis.

Zhang W, Navenot JM, Frilot NM, Fujii N, Peiper SC.

Mol Pharmacol. 2007 Nov;72(5):1310-21. Epub 2007 Aug 22.

PMID:
17715399
15.

SAR and QSAR studies on the N-terminally acylated pentapeptide agonists for GPR54.

Tomita K, Oishi S, Cluzeau J, Ohno H, Navenot JM, Wang ZX, Peiper SC, Akamatsu M, Fujii N.

J Med Chem. 2007 Jul 12;50(14):3222-8. Epub 2007 Jun 19.

PMID:
17579384
16.

Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancy.

Nash KT, Phadke PA, Navenot JM, Hurst DR, Accavitti-Loper MA, Sztul E, Vaidya KS, Frost AR, Kappes JC, Peiper SC, Welch DR.

J Natl Cancer Inst. 2007 Feb 21;99(4):309-21. Erratum in: J Natl Cancer Inst. 2007 Jul 20;99(12):977.

17.

Structure-activity relationship study on small peptidic GPR54 agonists.

Tomita K, Niida A, Oishi S, Ohno H, Cluzeau J, Navenot JM, Wang ZX, Peiper SC, Fujii N.

Bioorg Med Chem. 2006 Nov 15;14(22):7595-603. Epub 2006 Aug 1.

PMID:
16879969
18.

Characterization of constitutively active mutants of G protein-coupled receptors.

Navenot JM, Wang ZX, Peiper SC.

Methods Mol Biol. 2006;332:129-39.

PMID:
16878689
20.

Design and synthesis of downsized metastin (45-54) analogs with maintenance of high GPR54 agonistic activity.

Niida A, Wang Z, Tomita K, Oishi S, Tamamura H, Otaka A, Navenot JM, Broach JR, Peiper SC, Fujii N.

Bioorg Med Chem Lett. 2006 Jan 1;16(1):134-7. Epub 2005 Oct 18.

PMID:
16242330
21.

Constitutive activation of CCR5 and CCR2 induced by conformational changes in the conserved TXP motif in transmembrane helix 2.

Alvarez Arias D, Navenot JM, Zhang WB, Broach J, Peiper SC.

J Biol Chem. 2003 Sep 19;278(38):36513-21. Epub 2003 Jul 1.

22.

S-protein is expressed in necrotic fibers in Duchenne muscular dystrophy and polymyositis.

Louboutin JP, Navenot JM, Rouger K, Blanchard D.

Muscle Nerve. 2003 May;27(5):575-81.

PMID:
12707977
23.

CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion.

Libura J, Drukala J, Majka M, Tomescu O, Navenot JM, Kucia M, Marquez L, Peiper SC, Barr FG, Janowska-Wieczorek A, Ratajczak MZ.

Blood. 2002 Oct 1;100(7):2597-606.

24.

A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists.

Zhang WB, Navenot JM, Haribabu B, Tamamura H, Hiramatu K, Omagari A, Pei G, Manfredi JP, Fujii N, Broach JR, Peiper SC.

J Biol Chem. 2002 Jul 5;277(27):24515-21. Epub 2002 Mar 28.

25.

Role of CD4 hinge region in GP120 utilization by immunoglobulin domain 1.

Murray JL, Hu QX, Navenot JM, Peiper SC.

Biochem Biophys Res Commun. 2002 Mar 29;292(2):449-55.

PMID:
11906183
26.
27.

Identification of ENV determinants in V3 that influence the molecular anatomy of CCR5 utilization.

Hu Q, Trent JO, Tomaras GD, Wang Z, Murray JL, Conolly SM, Navenot JM, Barry AP, Greenberg ML, Peiper SC.

J Mol Biol. 2000 Sep 15;302(2):359-75.

PMID:
10970739
28.

Flow cytometric monitoring of red blood cell chimerism after bone marrow transplantation.

David B, Bernard D, Navenot JM, Muller JY, Blanchard D.

Transfus Med. 1999 Sep;9(3):209-17.

PMID:
10555815
29.

New method for quantitative determination of fetal hemoglobin-containing red blood cells by flow cytometry: application to sickle-cell disease.

Navenot JM, Merghoub T, Ducrocq R, Muller JY, Krishnamoorthy R, Blanchard D.

Cytometry. 1998 Jul 1;32(3):186-90.

PMID:
9667507
30.

X-linked vacuolated myopathy: membrane attack complex deposition on the surface membrane of injured muscle fibers is not accompanied by S-protein.

Louboutin JP, Navenot JM, Villanova M, Rouger K, Merlini L, Fardeau M.

Muscle Nerve. 1998 Jul;21(7):932-5.

PMID:
9626253
31.
32.

Expression of blood group i antigen and fetal hemoglobin in paroxysmal nocturnal hemoglobinuria.

Navenot JM, Muller JY, Blanchard D.

Transfusion. 1997 Mar;37(3):291-7.

PMID:
9122902
33.

Flow cytometry and immunoblotting analysis of monoclonal antibodies directed to complement regulatory proteins.

Blanchard D, Navenot JM, Petit-Le Roux Y, Willem C, Loirat MJ.

Transfus Clin Biol. 1997;4(1):131-4.

PMID:
9095519
34.

Expression of CD59, a regulator of the membrane attack complex of complement, on human skeletal muscle fibers.

Navenot JM, Villanova M, Lucas-Héron B, Malandrini A, Blanchard D, Louboutin JP.

Muscle Nerve. 1997 Jan;20(1):92-6.

PMID:
8995588
36.

Collagen matrix: an attractive alternative to agar and methylcellulose for the culture of hematopoietic progenitors in autologous transplantation products.

Dobo I, Allegraud A, Navenot JM, Boasson M, Bidet JM, Praloran V.

J Hematother. 1995 Aug;4(4):281-7.

PMID:
7489142
37.

Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor.

Charreau B, Cassard A, Tesson L, Le Mauff B, Navenot JM, Blanchard D, Lublin D, Soulillou JP, Anegon I.

Transplantation. 1994 Dec 15;58(11):1222-9.

PMID:
7527603
38.
39.

[Rapid diagnosis of paroxysmal nocturnal hemoglobinuria by gel test agglutination].

Navenot JM, Bernard D, Petit-Frioux Y, Loirat MJ, Guimbretière J, Muller JY, Blanchard D.

Rev Fr Transfus Hemobiol. 1993 Apr;36(2):135-47. French.

PMID:
7684909

Supplemental Content

Loading ...
Support Center